:max_bytes(150000):strip_icc()/GettyImages-1237662188-7e139af22fde43fba72b16f4f541834c.jpg?w=1920&resize=1920,1267&ssl=1 "Telix Pharmaceuticals Gets FDA Approval for Prostate Cancer Screening Agent | Global News Avenue")
Telix Pharmaceuticals Gets FDA Approval for Prostate Cancer Screening Agent
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1237662188-7e139af22fde43fba72b16f4f541834c.jpg)
Key Points
- Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent to direct prostate cancer screening.
- Gozellix is used for PET scan tests for men with positive prostate cancer lesions and patients with possible disease.
- The Australian biopharmaceutical company started trading in the U.S. four months ago and shares have increased by more than 20% since then.
Stock of Australia-based Telix Pharmaceuticals (TLX) rose 6% on Friday in the United States Food and Drug Administration (FDA) Agents from biopharmaceutical companies are approved for testing for screening for prostate cancer.
Telix explained that the drug Gozellix is used for prostate emission tomography (PET) prostate-specific membrane antigen (PSMA) scans “Prostate cancer has male-positive lesions that question metastasis and is a positive lesions that question metastasis and is a candidate for candidate initial therapy.” It is also designed for people with suspected recurrence based on elevated serum prostate-specific antigen (PSA) levels.
The company explained that Gozellix has a longer shelf life than the current coagulant-based imaging products on the market, “bringing the accuracy and clinical utility of coagulant-based film imaging to more patients in the United States.”
Telix Precision Medicine CEO Kevin Richardson called the FDA decision a “major victory for patients with prostate cancer.”
Telix Pharmaceutical stock only started our trading in November and has grown by more than 20% since then.
TradingView
:max_bytes(150000):strip_icc()/GettyImages-1237662188-7e139af22fde43fba72b16f4f541834c.jpg?w=1200&resize=1200,0&ssl=1&description=Telix+Pharmaceuticals+Gets+FDA+Approval+for+Prostate+Cancer+Screening+Agent+%7C+Global+News+Avenue){kind=link}